Induction of peroxiredoxins in transplanted livers and demonstration of their in vitro cytoprotection activity

Antioxidants and Redox Signaling

Volumn 2, Issue 2, 2000, Pages 347-354

  Shau, Hungyi ^a   Merino, Alejandro ^a   Chen, Lawrence ^b   Shih, Charles C Y ^c   Colquhoun, Steven D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c BD Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; PEROXIREDOXIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; FIBROBLAST; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; HUMAN; LIVER TRANSPLANTATION; NONHUMAN; ORGAN TRANSPLANTATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INDUCTION; TISSUE CULTURE;

ANIMALIA; MURINAE;

EID: 0033918405     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2000.2.2-347     Document Type: Article

References (38)

1. BUTTERFIELD, L.H., SHAU, H., MERINO, A., and GOLUB, S.H. (1999). From cytoprotection to tumor suppression - the multifactorial role of periredoxins. Antiox. Redox Signal. 1, 385-402.
2. BZEIZI, K.I., DAWKES, R., DODD, N.J., PLEVRIS, J.N., and HAYES, P.C. (1997). Graft dysfunction following liver transplantation: role of free radicals. J. Hepatol. 26, 69-74.
3. CHAE, H.Z., KIM, H.J., KANG, S.W., and RHEE, S.G. (1999). Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res. Clin. Pract. 45, 101-112.
4. CONNOLLY, D.T., KNIGHT, M.B., HARAKAS, N.K., WITTWER, A.J., and FEDER, J. (1986). Determination of the number of endothelial cells in culture using an acid phosphatase assay. Anal. Biochem. 152, 136-140.
5. FURUKE, K., SHIRAISHI, M., MOSTOWSKI, H.S., and BLOOM, E.T. (1999). Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway. J. Immunol. 162, 1988-1993.
6. GARDNER, A.M., XU, F.H., FADY, C., JACOBY, F.J., DUFFEY, D.C., TU, Y., and LICHTENSTEIN, A. (1997). Apoptotic vs. nonapoptotic cytotoxicity induced by hydrogen peroxide. Free Radic. Biol. Med. 22, 73-83.
7. HALLIWELL, B. (1996). Antioxidants in human health and disease. Annu. Rev. Nutr. 16, 33-50.
8. HAWLEY, R.G., LIEU, F.H., FONG, A.Z., and HAWLEY, T.S. (1994). Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1, 136-138.
9. IMMENSCHUH, S., NELL, C., IWAHARA, S., KATZ, N., and MULLER-EBERHARD, U. (1997). Gene regulation of HBP 23 by metalloporphyrins and protoporphyrin IX in liver and hepatocyte cultures. Biochem. Biophys. Res. Commun. 231, 667-670.
10. IWAHARA, S., SATOH, H., SONG, D.X., WEBB, J., BURLINGAME, A.L., NAGAE, Y., and MULLER-EBERHARD, U. (1995). Purification, characterization, and cloning of a heme-binding protein 23 kDa in rat liver cytosol. Biochemistry 34, 13398-13406.
11. KAKKIS, J.L., KE, B., DAWSON, S., MAGGARD, M., SI, M., KALDAS, F., CAI, W., SHAU, H., SEU, P., SAURI, H., BUSUTTIL, R.W., and IMAGAWA, D.K. (1997). Pravastatin increases survival and inhibits natural killer cell enhancement factor in liver transplanted rats. J. Surg. Res. 69, 393-398.
12. KANG, S.W., BAINES, I.C., and RHEE, S.G. (1998). Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J. Biol. Chem. 273, 6303-6311.
13. KANG, S.W., CHAE, H.Z., SEO, M.S., KIM, K., BAINES, I.C., and RHEE, S.G. (1998). Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J. Biol. Chem. 273, 6297-6302.
14. KATZNELSON, S., WANG, X.M., CHIA, D., OZAWA, M., ZHONG, H.P., HIRATA, M., TERASAKI, P.I., and KOBASHIGAWA, J.A. (1998). The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro. J. Heart Lung Transplant 17, 335-40.
15. KIM, A.T., SARAFIAN, T.A., and SHAU, H. (1997). Characterization of antioxidant properties of natural killer-enhanced factor-B and induction of its expression by hydrogen peroxide. Toxicol. Appl. Pharmacol. 147, 135-142.
16. KRISTENSEN, P., RASMUSSEN, D.E., and KRISTENSEN, B.I. (1999). Properties of thiol-specific anti-oxidant protein or calpromotin in solution. Biochem. Biophys. Res. Commun. 262, 127-131.
17. MIHM, S., GALTER, D., and DREOGE, W. (1995). Modulation of transcription factor NF kappa B activity by intracellular glutatathione levels and by variations of the extracellular cysteine supply. FASEB J. 9, 246-252.
18. MOORE, R.B., and SHRIVER, S.K. (1997). Protein 7.2b of human erythrocyte membranes binds to calpromotin. Biochem. Biophys. Res. Commun. 232, 294-297.
19. NAKAMURA, H., NAKAMURA, K., and YODOI, J. (1997). Redox regulation of cellular activation. Annu. Rev. Immunol. 15, 351-369.
20. NETTO, L.E.S., CHAE, H.Z., KANG, S.W., RHEE, S.G., and STADTMAN, E.R. (1996). Removal of hydrogen peroxide by thiol-specific antioxidant enzyme (TSA) is involved with its antioxidant properties. TSA possesses thiol peroxidase activity. J. Biol. Chem. 271, 15315-15321.
21. POOLE, L.B., CHAE, H.Z., FLORES, B.M., REED, S.L., RHEE, S.G., and TORIAN, B.E. (1997). Peroxidase activity of a TSA-like antioxidant protein from a pathogenic amoeba. Free Radic. Biol. Med. 23, 955-959.
22. PROSPAERI, M.T., FERBUS, D., KARCZINSKI, I., and GOUBIN, G. (1993). A human cDNA corresponding to a gene overexpressed during cell proliferation encodes a product sharing homology with amoebic and bacterial proteins. J. Biol. Chem. 268, 11050-11056.
23. RHEE, S.G., KIM, K.H., CHAE, H.Z., YIM, M.B., UCHIDA, K., NETTO, L.E., and STADTMAN, E.R. (1994). Antioxidant defense mechanisms: a new thiol-specific antioxidant enzyme. Ann. NY Acad. Sci. 738, 86-92.
24. SARAFIAN, T.A., RAJPER, N., GRIGORIAN, B., KIM, A., and SHAU, H. (1997). Cellular antioxidant properties of human natural killer enhancing factor B. Free Radic. Res. 26, 281-289.
25. SARAFIAN, T.A., VERITY, M.A., VINTERS, H.V., SHIH, C.C.-Y., SHI, L., JI, X.D., DONG, L., and SHAU, H. (1999). Differential expression of peroxiredoxin subtypes in human brain cell types. J. Neurosci. Res. 56, 206-212.
26. SATO, H., ISHII, T., SUGITA, Y., TATEISHI, N., and BANNAI, S. (1993). Induction of a 23 kDa stress protein by oxidative and sulfhydryl-reactive agents in mouse peritoneal macrophages. Biochim. Biophys. Acta 1148, 127-132.
27. SAURI, H., BUTTERFIELD, L., KIM, A., and SHAU, H. (1995). Antioxidant function of recombinant human natural killer enhancing factor. Biochem. Biophys. Res. Commun. 208, 964-969.
28. SAURI, H., ASHJIAN, P.H., KIM, A.T., and SHAU, H. (1996). Recombinant natural killer enhancing factor augments natural killer cytotoxicity. J. Leukoc. Biol. 59, 925-931.
29. SCHMID, I., UITTENBOGAART, C.H., KELD, B., and GIORGI, J.V. (1994). A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J. Immunol. Methods 170, 145-157.
30. SCHREODER, E., WILLIS, A.C., and PONTING, C.P. (1998). Porcine natural-killer-enhancing factor-B: oligomerisation and identification as a calpain substrate in vitro. Biochim. Biophys. Acta 1383, 279-291.
31. SEN, C.K., and PACKER, L. (1996). Antioxidant and redox regulation of gene transcription. FASEB J. 10, 709-720.
32. SERIZAWA, A., NAKAMURA, S., SUZUKI, BABA, S., and NAKANO, M. (1996). Involvement of platelet-activating factor in cytokine production and neutrophil activation after hepatic ischemia-reperfusion. Hepatology 23, 1656-1663.
33. SHAU, H., BUTTERFIELD, L.H., CHIU, R., and KIM, A. (1994). Cloning and sequence analysis of candidate human natural killer-enhancing factor genes. Immunogenetics 40, 129-134.
34. SHAU, H., KIM, A.T., HEDRICK, C.C., LUSIS, A.J., TOMPKINS, C., FINNEY, R., LEUNG, D.W., and PAGLIA, D.E. (1997). Endogenous natural killer enhancing factor-B increases cellular resistance to oxidative stresses. Free Radic. Biol. Med. 22, 497-507.
35. SHAU, H., HUANG, A.C., FARIS, M., NAZARIAN, R., DE VELLIS, J., and CHEN, W. (1998). Thioredoxin peroxidase (natural killer enhancing factor) regulation of activator protein-1 function in endothelial cells. Biochem. Biophys. Res. Commun. 249, 683-686.
36. TRINCHIERI, G. (1989). Biology of natural killer cells. Adv. Immunol. 47, 187-376.
37. WEN, S.T., and VAN ETTEN, R.A. (1997). The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev. 11, 2456-2467.
38. ZHANG, P., LIU, B., KANG, S.W., SEO, M.S., RHEE, S.G., and OBEID, L.M. (1997). Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J. Biol. Chem. 272, 30615-30618.